{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:42:58Z","timestamp":1786203778622,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002951","name":"Dokkyo Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002951","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Among several adverse events induced by chemotherapy for patients with far advanced and unresectable cancer, oral mucositis is one that reduces patient quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the preventive effects of hangeshashinto on oral mucositis induced by chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a comprehensive electronic literature search (PubMed, the Web of Science, and CENTRAL) up to March 2024 to identify studies showing the efficacy of hangeshashinto administration for preventing oral mucositis in patients receiving chemotherapy. To integrate the individual preventive effect of hangeshashinto, a meta-analysis was performed using random-effects models to calculate the risk ratio and 95% confidence interval, and heterogeneity was analyzed using\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      statistics. In this analysis, oral mucositis was defined as more than grade 1 mucositis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This meta-analysis included six studies (five randomized controlled trials and one case-matched study) involving 293 patients with cancer receiving chemotherapy. Among 141 patients who received hangeshashinto during chemotherapy, 65 (46.1%) developed oral mucositis; in contrast, among 152 patients who did not receive hangeshashinto or received a placebo, 78 (51.3%) developed oral mucositis. The meta-analysis suggested that hangeshashinto may reduce the risk of oral mucositis (risk ratio\u2009=\u20090.86, 95% confidence interval\u2009=\u20090.73\u20131.00,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.05,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%) compared with no hangeshashinto or placebo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results of this meta-analysis suggest that hangeshashinto may have a preventive effect against chemotherapy-induced oral mucositis. However, further well-designed randomized controlled trials are required to confirm its preventive efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-10975-6","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:38:15Z","timestamp":1783604295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hangeshashinto for the prevention of oral mucositis in patients receiving chemotherapy: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-1480","authenticated-orcid":false,"given":"Mitsuru","family":"Ishizuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norisuke","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hachiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsutaro","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunekazu","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"10975_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.surg.2009.06.012","volume":"146","author":"T Kono","year":"2009","unstructured":"Kono T, Kanematsu T, Kitajima M (2009) Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines: is it time yet? Surgery 146:837\u2013840","journal-title":"Surgery"},{"key":"10975_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00280-003-0585-0","volume":"51","author":"K Mori","year":"2003","unstructured":"Mori K, Kondo T, Kamiyama Y et al (2003) Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 51:403\u2013406","journal-title":"Cancer Chemother Pharmacol"},{"key":"10975_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2015.00014","volume":"6","author":"S Ohnishi","year":"2015","unstructured":"Ohnishi S, Takeda H (2015) Herbal medicines for the treatment of cancer chemotherapy-induced side effects. Front Pharmacol 6:14","journal-title":"Front Pharmacol"},{"key":"10975_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/medicines5040130","author":"M Sunagawa","year":"2018","unstructured":"Sunagawa M, Yamaguchi K, Tsukada M et al (2018) Kampo (traditional Japanese herbal) formulae for treatment of stomatitis and oral mucositis. Medicines (Basel). https:\/\/doi.org\/10.3390\/medicines5040130","journal-title":"Medicines (Basel)"},{"key":"10975_CR5","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.7150\/jca.46748","volume":"11","author":"T Aoyama","year":"2020","unstructured":"Aoyama T, Tamagawa H (2020) The clinical effect of Kampo medicine in multimodal treatment for gastrointestinal cancer in Japan. J Cancer 11:5390\u20135394","journal-title":"J Cancer"},{"key":"10975_CR6","unstructured":"Scardina GA, Pisano T, Messina P. Oral mucositis. Review of literature. N Y State Dent J 2010;76:34\u20138."},{"key":"10975_CR7","unstructured":"Napenas JJ, Shetty KV, Streckfus CF. Oral mucositis: review of pathogenesis, diagnosis, prevention, and management. Gen Dent 2007;55:335\u201344; quiz 345\u20136, 376."},{"key":"10975_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1601-0825.2006.01258.x","volume":"12","author":"C Scully","year":"2006","unstructured":"Scully C, Sonis S, Diz PD (2006) Oral mucositis. Oral Dis 12:229\u2013241","journal-title":"Oral Dis"},{"key":"10975_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cncr.22484","volume":"109","author":"DM Keefe","year":"2007","unstructured":"Keefe DM, Schubert MM, Elting LS et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820\u2013831","journal-title":"Cancer"},{"key":"10975_CR10","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1002\/cncr.23898","volume":"113","author":"LS Elting","year":"2008","unstructured":"Elting LS, Keefe DM, Sonis ST et al (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113:2704\u20132713","journal-title":"Cancer"},{"key":"10975_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1254\/jjp.75.407","volume":"75","author":"Y Kase","year":"1997","unstructured":"Kase Y, Hayakawa T, Aburada M et al (1997) Preventive effects of Hange-shashin-to on irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat. Jpn J Pharmacol 75:407\u2013413","journal-title":"Jpn J Pharmacol"},{"key":"10975_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1248\/bpb.21.117","volume":"21","author":"Y Kase","year":"1998","unstructured":"Kase Y, Saitoh K, Yuzurihara M et al (1998) Effects of Hange-shashin-to on cholera toxin-induced fluid secretion in the small intestine of rats. Biol Pharm Bull 21:117\u2013120","journal-title":"Biol Pharm Bull"},{"key":"10975_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/(SICI)1099-1573(199909)13:6<468::AID-PTR504>3.0.CO;2-V","volume":"13","author":"Y Kase","year":"1999","unstructured":"Kase Y, Saitoh K, Makino B et al (1999) Relationship between the antidiarrhoeal effects of Hange-Shashin-To and its active components. Phytother Res 13:468\u2013473","journal-title":"Phytother Res"},{"key":"10975_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/512947","volume":"2015","author":"H Fukamachi","year":"2015","unstructured":"Fukamachi H, Matsumoto C, Omiya Y et al (2015) Effects of Hangeshashinto on growth of oral microorganisms. Evid Based Complement Alternat Med 2015:512947","journal-title":"Evid Based Complement Alternat Med"},{"key":"10975_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2147\/CMAR.S238306","volume":"12","author":"N Ozawa","year":"2020","unstructured":"Ozawa N, Onda T, Hayashi K et al (2020) Effects of topical Hangeshashinto (TJ-14) on chemotherapy-induced oral mucositis. Cancer Manag Res 12:1069\u20131078","journal-title":"Cancer Manag Res"},{"key":"10975_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57192-2","volume":"10","author":"K Miyano","year":"2020","unstructured":"Miyano K, Eto M, Hitomi S et al (2020) The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis. Sci Rep 10:625","journal-title":"Sci Rep"},{"key":"10975_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/1534735413520035","volume":"13","author":"T Kono","year":"2014","unstructured":"Kono T, Kaneko A, Matsumoto C et al (2014) Multitargeted effects of hangeshashinto for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin E2 production in human oral keratinocytes. Integr Cancer Ther 13:435\u2013445","journal-title":"Integr Cancer Ther"},{"key":"10975_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s12094-017-1672-8","volume":"19","author":"D Kamide","year":"2017","unstructured":"Kamide D, Yamashita T, Araki K et al (2017) Hangeshashinto (TJ-14) prevents radiation-induced mucositis by suppressing cyclooxygenase-2 expression and chemotaxis of inflammatory cells. Clin Transl Oncol 19:1329\u20131336","journal-title":"Clin Transl Oncol"},{"key":"10975_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00520-014-2315-z","volume":"23","author":"T Yamashita","year":"2015","unstructured":"Yamashita T, Araki K, Tomifuji M et al (2015) A traditional Japanese medicine\u2013Hangeshashinto (TJ-14)\u2013alleviates chemoradiation-induced mucositis and improves rates of treatment completion. Support Care Cancer 23:29\u201335","journal-title":"Support Care Cancer"},{"key":"10975_CR20","first-page":"232","volume":"1","author":"T Kono","year":"2010","unstructured":"Kono T, Satomi M, Chisato N et al (2010) Topical application of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis. World J Oncol 1:232\u2013235","journal-title":"World J Oncol"},{"key":"10975_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00280-015-2767-y","volume":"76","author":"C Matsuda","year":"2015","unstructured":"Matsuda C, Munemoto Y, Mishima H et al (2015) Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis. Cancer Chemother Pharmacol 76:97\u2013103","journal-title":"Cancer Chemother Pharmacol"},{"key":"10975_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2152\/jmi.65.184","volume":"65","author":"S Moriyama","year":"2018","unstructured":"Moriyama S, Hinode D, Yoshioka M et al (2018) Impact of the use of Kampo medicine in patients with esophageal cancer during chemotherapy:a clinical trial for oral hygiene and oral condition. J Med Invest 65:184\u2013190","journal-title":"J Med Invest"},{"key":"10975_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.33160\/yam.2020.08.007","volume":"63","author":"K Taira","year":"2020","unstructured":"Taira K, Fujiwara K, Fukuhara T et al (2020) The effect of Hangeshashinto on oral mucositis caused by induction chemotherapy in patients with head and neck cancer. Yonago Acta Med 63:183\u2013187","journal-title":"Yonago Acta Med"},{"key":"10975_CR24","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00280-014-2440-x","volume":"73","author":"T Aoyama","year":"2014","unstructured":"Aoyama T, Nishikawa K, Takiguchi N et al (2014) Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis. Cancer Chemother Pharmacol 73:1047\u20131054","journal-title":"Cancer Chemother Pharmacol"},{"key":"10975_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.9738\/INTSURG-D-17-00114.1","volume":"103","author":"M Takahashi","year":"2018","unstructured":"Takahashi M, Nakajima M, Muroi H et al (2018) Prevention of the chemotherapy-induced oral mucositis in esophageal cancer by use of Hangeshashinto (TJ-14). Int Surg 103:401\u2013404","journal-title":"Int Surg"},{"key":"10975_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.21873\/invivo.13149","volume":"37","author":"T Kato","year":"2023","unstructured":"Kato T, Sakagami H (2023) Efficacy of cryotherapy and Hangeshashinto for radiation-induced oral stomatitis: preliminary study. In Vivo 37:830\u2013835","journal-title":"In Vivo"},{"key":"10975_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/15347354241242110","volume":"23","author":"Y He","year":"2024","unstructured":"He Y, Wu L, Qi X et al (2024) Efficiency of protective interventions on irinotecan-induced diarrhea: a systematic review and meta-analysis. Integr Cancer Ther 23:15347354241242110","journal-title":"Integr Cancer Ther"},{"key":"10975_CR28","volume":"15","author":"T Takahashi","year":"2023","unstructured":"Takahashi T, Nagai K, Kotake K (2023) Efficacy of Hangeshashinto in the prevention of chemotherapy-induced diarrhea: a systematic review and meta-analysis. Cureus 15:e50377","journal-title":"Cureus"},{"key":"10975_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-047627","volume":"11","author":"YT Wang","year":"2021","unstructured":"Wang YT, Ren Y, Xiao C et al (2021) Hangeshashinto for preventing oral mucositis in patients receiving cancer treatment: protocol for a systematic review and meta-analysis. BMJ Open 11:e047627","journal-title":"BMJ Open"},{"key":"10975_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol 134:178\u2013189","journal-title":"J Clin Epidemiol"},{"key":"10975_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"key":"10975_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"10975_CR33","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","journal-title":"BMJ"},{"key":"10975_CR34","first-page":"5967","volume":"37","author":"M Ishizuka","year":"2017","unstructured":"Ishizuka M, Shibuya N, Nagata H et al (2017) Perioperative administration of traditional Japanese herbal medicine Daikenchuto relieves postoperative ileus in patients undergoing surgery for gastrointestinal cancer: a systematic review and meta-analysis. Anticancer Res 37:5967\u20135974","journal-title":"Anticancer Res"},{"key":"10975_CR35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s10147-019-01502-1","volume":"24","author":"M Hosaka","year":"2019","unstructured":"Hosaka M, Arai I, Ishiura Y et al (2019) Efficacy of daikenchuto, a traditional Japanese Kampo medicine, for postoperative intestinal dysfunction in patients with gastrointestinal cancers: meta-analysis. Int J Clin Oncol 24:1385\u20131396","journal-title":"Int J Clin Oncol"},{"key":"10975_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4174\/astr.2018.95.1.7","volume":"95","author":"L Zhang","year":"2018","unstructured":"Zhang L, Cheng Y, Li H et al (2018) Meta-analysis of randomized controlled trials on the efficacy of daikenchuto on improving intestinal dysfunction after abdominal surgery. Ann Surg Treat Res 95:7\u201315","journal-title":"Ann Surg Treat Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10975-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10975-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10975-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:56:04Z","timestamp":1786200964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10975-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10975"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10975-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"749"}}